Free Trial

NantHealth (NH) Competitors

$0.90
+0.05 (+5.88%)
(As of 05/28/2024 ET)

NH vs. NHIQ, GRAY, IMCC, BRTX, VCNX, MEDS, SYRA, RNAZ, PRPO, and CANF

Should you be buying NantHealth stock or one of its competitors? The main competitors of NantHealth include NantHealth (NHIQ), Graybug Vision (GRAY), IM Cannabis (IMCC), BioRestorative Therapies (BRTX), Vaccinex (VCNX), TRxADE HEALTH (MEDS), Syra Health (SYRA), TransCode Therapeutics (RNAZ), Precipio (PRPO), and Can-Fite BioPharma (CANF). These companies are all part of the "medical" sector.

NantHealth vs.

NantHealth (NASDAQ:NHIQ) and NantHealth (NASDAQ:NH) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, community ranking, media sentiment, analyst recommendations and institutional ownership.

NantHealth has a beta of 1.39, suggesting that its stock price is 39% more volatile than the S&P 500. Comparatively, NantHealth has a beta of 1.82, suggesting that its stock price is 82% more volatile than the S&P 500.

NantHealth has a net margin of -94.67% compared to NantHealth's net margin of -109.49%.

Company Net Margins Return on Equity Return on Assets
NantHealth-109.49% N/A -38.79%
NantHealth -94.67%N/A -39.82%

In the previous week, NantHealth had 1 more articles in the media than NantHealth. MarketBeat recorded 1 mentions for NantHealth and 0 mentions for NantHealth. NantHealth's average media sentiment score of 0.00 equaled NantHealth'saverage media sentiment score.

Company Overall Sentiment
NantHealth Neutral
NantHealth Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NantHealth$67M0.44-$67.78MN/AN/A
NantHealth$67.68M0.10-$67.78M-$7.65-0.12

NantHealth received 271 more outperform votes than NantHealth when rated by MarketBeat users.

CompanyUnderperformOutperform
NantHealthN/AN/A
NantHealthOutperform Votes
271
50.84%
Underperform Votes
262
49.16%

4.5% of NantHealth shares are held by institutional investors. 61.3% of NantHealth shares are held by company insiders. Comparatively, 61.3% of NantHealth shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NantHealth
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
NantHealth
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

NantHealth beats NantHealth on 6 of the 9 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NH vs. The Competition

MetricNantHealthData processing & preparation IndustryMedical SectorNASDAQ Exchange
Market Cap$6.93M$3.47B$4.99B$8.09B
Dividend YieldN/A2.17%2.74%3.96%
P/E Ratio-0.1224.07175.1318.36
Price / Sales0.105.722,498.8372.31
Price / CashN/A48.6232.9328.77
Price / Book-0.037.364.944.39
Net Income-$67.78M$43.41M$104.17M$213.55M
7 Day Performance-18.18%-0.20%-0.65%-0.81%
1 Month Performance51.97%6.03%3.82%3.42%
1 Year Performance-33.33%5.85%5.45%7.52%

NantHealth Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NHIQ
NantHealth
0 of 5 stars
$0.84
-23.6%
N/A-36.9%$27.39M$67M0.00365Gap Up
GRAY
Graybug Vision
0 of 5 stars
$5.40
-0.9%
N/A+68.3%$8.48MN/A-3.1227
IMCC
IM Cannabis
0.7116 of 5 stars
$0.63
-4.5%
N/A-43.3%$8.50M$48.34M-0.7995Short Interest ↑
Positive News
Gap Up
BRTX
BioRestorative Therapies
2.9198 of 5 stars
$1.26
-2.3%
N/AN/A$8.53M$150,000.00-0.3611Short Interest ↓
VCNX
Vaccinex
1.8499 of 5 stars
$5.40
-1.8%
N/A-93.7%$8.53M$570,000.00-0.0737
MEDS
TRxADE HEALTH
0 of 5 stars
$5.88
+2.3%
N/A+37.7%$8.29M$8.27M-0.858News Coverage
SYRA
Syra Health
0 of 5 stars
$1.35
+1.5%
N/AN/A$8.67M$5.51M0.0078News Coverage
Gap Up
RNAZ
TransCode Therapeutics
2.222 of 5 stars
$1.25
+5.0%
$3.00
+140.0%
-99.1%$8.28MN/A0.0010Upcoming Earnings
Short Interest ↑
Gap Up
PRPO
Precipio
1.594 of 5 stars
$5.90
-1.7%
$40.00
+578.0%
-54.5%$8.67M$15.20M-1.7351Short Interest ↓
CANF
Can-Fite BioPharma
0.888 of 5 stars
$2.46
-0.4%
$15.00
+511.0%
+10.3%$8.69M$743,000.00-1.378News Coverage

Related Companies and Tools

This page (NASDAQ:NH) was last updated on 5/28/2024 by MarketBeat.com Staff

From Our Partners